171 related articles for article (PubMed ID: 16583316)
1. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease.
Lumbreras M; Baamonde C; Martínez-Cué C; Lubec G; Cairns N; Sallés J; Dierssen M; Flórez J
Amino Acids; 2006 Nov; 31(4):449-56. PubMed ID: 16583316
[TBL] [Abstract][Full Text] [Related]
2. G-protein-associated signal transduction processes are restored after postweaning environmental enrichment in Ts65Dn, a Down syndrome mouse model.
Baamonde C; Martínez-Cué C; Flórez J; Dierssen M
Dev Neurosci; 2011; 33(5):442-50. PubMed ID: 21865666
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms.
Karelson E; Fernaeus S; Reis K; Bogdanovic N; Land T
J Neurosci Res; 2005 Feb; 79(3):368-74. PubMed ID: 15614786
[TBL] [Abstract][Full Text] [Related]
4. 17beta-Oestradiol stimulation of G-proteins in aged and Alzheimer's human brain: comparison with phytoestrogens.
Jefremov V; Rakitin A; Mahlapuu R; Zilmer K; Bogdanovic N; Zilmer M; Karelson E
J Neuroendocrinol; 2008 May; 20(5):587-96. PubMed ID: 18363809
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.
Kim SH; Yoo BC; Broers JL; Cairns N; Lubec G
Biochem Biophys Res Commun; 2000 Sep; 276(1):329-34. PubMed ID: 11006125
[TBL] [Abstract][Full Text] [Related]
6. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
Albasanz JL; Dalfó E; Ferrer I; Martín M
Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
[TBL] [Abstract][Full Text] [Related]
7. GTP gamma S and forskolin-stimulated adenylyl cyclase activity in post-mortem brain from depressed suicides and controls.
Lowther S; Crompton MR; Katona CL; Horton RW
Mol Psychiatry; 1996 Dec; 1(6):470-7. PubMed ID: 9154249
[TBL] [Abstract][Full Text] [Related]
8. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
Muma NA; Mariyappa R; Williams K; Lee JM
Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
[TBL] [Abstract][Full Text] [Related]
9. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
Greber S; Lubec G; Cairns N; Fountoulakis M
Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
[TBL] [Abstract][Full Text] [Related]
10. Reduced phospholipase C-beta activity and isoform expression in the cerebellum of TS65Dn mouse: a model of Down syndrome.
Ruiz de Azúa I; Lumbreras MA; Zalduegui A; Baamonde C; Dierssen M; Flórez J; Sallés J
J Neurosci Res; 2001 Nov; 66(4):540-50. PubMed ID: 11746373
[TBL] [Abstract][Full Text] [Related]
11. Evidence for multiple distinctly localized adenylyl cyclase isoforms in mammalian spermatozoa.
Baxendale RW; Fraser LR
Mol Reprod Dev; 2003 Oct; 66(2):181-9. PubMed ID: 12950106
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of adenylyl cyclase activity in brain membrane fractions by arachidonic acid and related unsaturated fatty acids.
Nakamura J; Okamura N; Usuki S; Bannai S
Arch Biochem Biophys; 2001 May; 389(1):68-76. PubMed ID: 11370673
[TBL] [Abstract][Full Text] [Related]
13. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
Yoo BC; Fountoulakis M; Cairns N; Lubec G
Electrophoresis; 2001 Jan; 22(1):172-9. PubMed ID: 11197169
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane signaling through phospholipase C-beta in the developing human prefrontal cortex.
Ruiz de Azúa I; del Olmo E; Pazos A; Sallés J
J Neurosci Res; 2006 Jul; 84(1):13-26. PubMed ID: 16615043
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
16. Down syndrome and Alzheimer's disease: a link between development and aging.
Lott IT; Head E
Ment Retard Dev Disabil Res Rev; 2001; 7(3):172-8. PubMed ID: 11553933
[TBL] [Abstract][Full Text] [Related]
17. Critical role of methionine-722 in the stimulation of human brain G-proteins and neurotoxicity induced by London familial Alzheimer's disease (FAD) mutated V717G-APP(714-723).
Reis K; Zharkovsky A; Bogdanovic N; Karelson E; Land T
Neuroscience; 2007 Jan; 144(2):571-8. PubMed ID: 17101228
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease.
Cheon MS; Bajo M; Gulesserian T; Cairns N; Lubec G
Electrophoresis; 2001 Feb; 22(3):445-8. PubMed ID: 11258753
[TBL] [Abstract][Full Text] [Related]
19. Reduced short latency afferent inhibition in patients with Down syndrome and Alzheimer-type dementia.
Nardone R; Marth R; Ausserer H; Bratti A; Tezzon F
Clin Neurophysiol; 2006 Oct; 117(10):2204-10. PubMed ID: 16931146
[TBL] [Abstract][Full Text] [Related]
20. Loss of stimulatory effect of guanosine triphosphate on [(35)S]GTPgammaS binding correlates with Alzheimer's disease neurofibrillary pathology in entorhinal cortex and CA1 hippocampal subfield.
García-Jiménez A; Cowburn RF; Ohm TG; Lasn H; Winblad B; Bogdanovic N; Fastbom J
J Neurosci Res; 2002 Feb; 67(3):388-98. PubMed ID: 11813244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
